Company Quick10K Filing
MorphoSys AG
20-F 2019-12-31 Filed 2020-03-18
20-F 2018-12-31 Filed 2019-03-13

MorphoSys AG Financials

MOR Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Epizyme (EPZM) 933,457 0% -4.7 -41% 334,197 40,459 29,206 0 -136,838 -136,155 640,557
Odonate Therapeutics (ODT) 889,368 -8.2 -39% 212,787 26,586 0 0 -83,974 -83,705 684,872
Kura Oncology (KURA) 878,309 -18.5 -18% 254,602 21,018 0 0 -45,275 -44,837 831,067
ANI Pharmaceuticals (ANIP) 871,691 52% 19.9 2% 456,775 243,645 215,703 113,222 10,929 43,947 876,020
Homology Medicines (FIXX) 860,220 0% -9.8 -25% 316,759 58,937 1,103 0 -79,749 -79,749 781,387
Axsome Therapeutics (AXSM) 857,937 -15.7 -120% 44,440 37,617 0 0 -53,135 -53,135 834,295
Phibro Animal Health (PAHC) 852,609 42% 11.2 5% 795,239 588,545 613,679 256,482 40,914 91,740 1,025,862
Arqule (ARQL) 844,628 0% -22.0 -21% 180,342 27,216 1,834 0 -38,585 -37,215 817,012
Omeros (OMER) 815,685 78% -13.3 -86% 91,263 231,178 100,405 77,924 -78,795 -60,688 806,824
MorphoSys AG (MOR) 810,636 0% 538,764 50,391 0 0 0 0 765,160
Wave Life Sciences (WVE) 770,709 0% -3.2 -50% 347,212 224,565 17,203 0 -174,755 -174,755 558,057
Vanda (VNDA) 768,898 21% 20.4 26% 474,449 73,542 219,299 46,994 121,697 35,735 728,948
Ziopharm Oncology (ZIOP) 763,947 7.3 78% 117,949 11,823 0 0 92,488 92,488 675,528
Kiniksa Pharmaceuticals (KNSA) 759,962 -2.9 -61% 281,805 29,894 0 0 -172,650 -174,871 501,217
Arvinas (ARVN) 752,492 0% -11.6 -31% 209,094 74,934 41,523 0 -65,332 -64,214 742,356
Principia Biopharma (PRNB) 739,297 0% -36.4 -11% 174,087 21,412 61,297 0 -19,491 -19,491 709,319
Eagle Pharmaceuticals (EGRX) 735,537 53% 27.4 5% 257,038 81,273 203,687 107,768 13,308 23,988 658,326
Rhythm Pharmaceuticals (RYTM) 732,720 -4.3 -75% 177,533 28,418 0 0 -133,280 -132,637 570,285
Nabriva Therapeutics (NBRV) 726,126 69% -7.7 -100% 90,122 50,907 9,945 6,905 -90,543 -88,048 682,038
Endo (ENDP) 723,374 45% 1,733.8 -5% 9,834,866 10,496,343 2,935,953 1,333,457 -495,901 4,240 7,351,337

Balance Sheet ($'000)2018-12-31
Cash45,476
Accounts Receivable
Inventory
PP&E
Assets538,764
Accounts Payable
Long-Term Debt
Liabilities50,391
Stockholders' Equity
Income Statement ($'000)2018-12-31
Revenue
Cost of Revenue
Gross Profit
R&D
SG&A
Tax
Net Income
Cash Flow ($'000)2018-12-31
Cash Operating
Cash Investing
Cash Financing